A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients

Recruiting

Phase 3

PTP-001A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients

Sponsor:

Doron Therapeutics Inc.

Code:

NCT07219771

Conditions

Knee Osteoarthritis

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

PTP-01

Placebo control / saline vehicle

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-07. This information was provided to ClinicalTrials.gov by Doron Therapeutics Inc. on 2026-04-29.